AU2001231232A1 - Recombinant multivalent malarial vaccines against plasmodium vivax - Google Patents

Recombinant multivalent malarial vaccines against plasmodium vivax

Info

Publication number
AU2001231232A1
AU2001231232A1 AU2001231232A AU3123201A AU2001231232A1 AU 2001231232 A1 AU2001231232 A1 AU 2001231232A1 AU 2001231232 A AU2001231232 A AU 2001231232A AU 3123201 A AU3123201 A AU 3123201A AU 2001231232 A1 AU2001231232 A1 AU 2001231232A1
Authority
AU
Australia
Prior art keywords
vaccines against
plasmodium vivax
against plasmodium
recombinant multivalent
malarial vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231232A
Inventor
Altaf A Lal
Lihua Xiao
Zhiyong Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centers of Disease Control and Prevention CDC
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001231232A1 publication Critical patent/AU2001231232A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001231232A 2000-01-31 2001-01-29 Recombinant multivalent malarial vaccines against plasmodium vivax Abandoned AU2001231232A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17921300P 2000-01-31 2000-01-31
US60179213 2000-01-31
PCT/US2001/002937 WO2001055181A2 (en) 2000-01-31 2001-01-29 Recombinant multivalent malarial vaccines against plasmodium vivax

Publications (1)

Publication Number Publication Date
AU2001231232A1 true AU2001231232A1 (en) 2001-08-07

Family

ID=22655693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231232A Abandoned AU2001231232A1 (en) 2000-01-31 2001-01-29 Recombinant multivalent malarial vaccines against plasmodium vivax

Country Status (2)

Country Link
AU (1) AU2001231232A1 (en)
WO (1) WO2001055181A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006214694B2 (en) * 2005-01-18 2011-09-08 Walter Reed Army Institute Of Research A plasmodium vivax hybrid circumsporozoite protein and vaccine
US7749519B2 (en) * 2005-12-09 2010-07-06 Kim Lee Sim Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
US20110262469A1 (en) * 2006-10-04 2011-10-27 Centro Internacional De Vacunas Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax
BRPI0924581A2 (en) * 2009-05-05 2016-07-19 Univ Minas Gerais genetically modified plasmodium vivax antigen sequences, vaccine compositions containing recombinant proteins and recombinant viruses expressing these antigens, and dose-boosting malaria vaccination method
US11013791B2 (en) 2017-06-22 2021-05-25 The Government Of The United States, As Represented By The Secretary Of The Army NYVAC-based plasmodium malaria vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762945B2 (en) * 1998-08-21 2003-07-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Recombinant multivalent malarial vaccine against plasmodium falciparum

Also Published As

Publication number Publication date
WO2001055181A2 (en) 2001-08-02
WO2001055181A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
EP1309602A4 (en) Malaria immunogen and vaccine
IL155282A0 (en) Vaccines
PT1361893E (en) Modified anti-egfr antibodies with reduced immunogenicity
GB0020953D0 (en) Vaccine
HUP0301043A3 (en) Vaccine
IL155072A0 (en) Vaccine
EP1423405A4 (en) Plasmodium falciparum ama-1 protein and uses thereof
HUP0402259A3 (en) Vaccines
AU1591402A (en) Vaccine
GB0024200D0 (en) Component vaccine
EP1423141A4 (en) Vaccine
AU2002248392A1 (en) Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
GB0014288D0 (en) Vaccine
PL363181A1 (en) Modified interferon alpha with reduced immunogenicity
AU2001231232A1 (en) Recombinant multivalent malarial vaccines against plasmodium vivax
AU1600401A (en) Malaria vaccine
PL349861A1 (en) Malaria vaccine
IL158124A0 (en) Leishmania vaccines
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
GB0025694D0 (en) Vaccine
EP1249161A4 (en) Floating head eye
GB0003082D0 (en) Vaccine
GB0004533D0 (en) Vaccines
GB0006693D0 (en) Vaccine